Micaela Robotti
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Profiling the real-world migraine patient: public health insights from sociodemographic, lifestyle, and clinical data in the Italian National Migraine Registry (I-GRAINE).
Journal: The journal of headache and pain
Published: July 28, 2025
Correction to: Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.
Journal: Neurology and therapy
Published: August 06, 2024
Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Journal: Journal of neurology
Published: April 02, 2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study.
Journal: Neurology and therapy
Published: December 04, 2023
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Journal: Journal of neurology
Published: October 03, 2023
Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis.
Journal: The journal of headache and pain
Published: January 05, 2022
Comorbidities of primary headache disorders: a literature review with meta-analysis.
Journal: The journal of headache and pain
Published: June 14, 2021
Late onset absolute neutropenia associated with ocrelizumab treatment in multiple sclerosis: A case report and review of the literature.
Journal: Journal of the neurological sciences
Published: October 23, 2019
Severe disease activity in a patient with multiple sclerosis after daclizumab discontinuation.
Journal: Multiple sclerosis and related disorders
Published: September 15, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026